PPD sales rise as CRO sector stays buoyant

By Kirsty barnes

- Last updated on GMT

PPD saw its sales rise 17 per cent in the fourth quarter, fuelled
by its large Development segment.

The US-based contract research organisation (CRO) also reported a 23 per cent rise in operating profit to $58m (€45m) and a pre-tax profit jump of 32 per cent to $62.3m.

These increases are typical of business performances being achieved by other large international CROs as this sector of pharmaceutical outsourcing remains buoyant.

Rival firm Parexel, for example, recently reported that its sales for the three months ending 31 December rose 21 per cent to $180.5m, while also recording a substantial 31 per cent increase in operating income to $13.9m, from $10.6m in the same quarter last year.

Meanwhile, all was not well with PPD in Q4. Despite a revenue increase of 23 per cent to $5.2m, the company's small Discovery Sciences segment continued to remain loss-making, with a loss from operations of $700,000, a slight improvement on the $1.2m loss posted in the comparable 2005 quarter.

Direct spending on the segment was also kept to a minimum by the firm, increasing only 10 per cent.

The company was unavailable for comment.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars